The prognostic utility of the SYNTAX score on 1-year outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial

Garg, Scot; Serruys, Patrick W; Silber, Sigmund; Wykrzykowska, Joanna; van Geuns, Robert Jan; Richardt, Gert; Buszman, Pawel E; Kelbæk, Henning; van Boven, Adrianus Johannes; Hofma, Sjoerd H; Linke, Axel; Klauss, Volker; Wijns, William; Macaya, Carlos; Garot, Philippe; DiMario, Carlo; Manoharan, Ganesh; Kornowski, Ran; Ischinger, Thomas; Bartorelli, Antonio; ... (2011). The prognostic utility of the SYNTAX score on 1-year outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial. JACC. Cardiovascular Interventions, 4(4), pp. 432-41. New York, N.Y.: Elsevier 10.1016/j.jcin.2011.01.008

Full text not available from this repository.

This study assessed the ability of the SYNTAX score (SXscore) to stratify risk in patients treated with percutaneous coronary intervention (PCI) using zotarolimus-eluting or everolimus-eluting stents.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiology

UniBE Contributor:

Windecker, Stephan

ISSN:

1876-7605

Publisher:

Elsevier

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:21

Last Modified:

05 Dec 2022 14:06

Publisher DOI:

10.1016/j.jcin.2011.01.008

PubMed ID:

21511223

Web of Science ID:

000290128100008

URI:

https://boris.unibe.ch/id/eprint/7229 (FactScience: 212416)

Actions (login required)

Edit item Edit item
Provide Feedback